Status:
RECRUITING
Segmental Vibrator With NMES on Lower Limb Function in Subacute Stroke
Lead Sponsor:
Riphah International University
Conditions:
Subacute Stroke
Ischemic Stroke
Eligibility:
All Genders
45-60 years
Phase:
NA
Brief Summary
Stroke is one of the world's leading causes of death and disability. It can cause a variety of motor disorders, such as apraxia, sensory deficits, abnormal muscle tone, inadequate weight transfer, lac...
Detailed Description
The definition of a stroke, as given by the World Health Organization (WHO), is a clinical illness that includes focused disruptions in cerebral functioning that develop quickly and have a vascular or...
Eligibility Criteria
Inclusion
- Both male and female patients were included in the study.
- The age range of participants was between 45 and 60 years.
- Participants that were diagnosed with ischemic stroke patient.
- Participants had experienced sub-acute ischemic stroke, specifically 15 days to 12 weeks post-stroke.
- Montreal Cognitive Assessment scores falling within the range of 18-24 were necessary.
- Modified Ashworth scale scores had to be less than +1
- National Institutes of Health Stroke Scale (NIHSS) score falling within the range of 1 to 15 were necessary.
- Participants feel no pain from the vibrator.
- It was anticipated that participants would either be able to give informed consent or have a legal representative who could do so.
Exclusion
- People who had a history of serious neurological or mental conditions that would have impeded lower limb motor recovery-aside from stroke-were not included.
- Individuals with severe arthritis or joint injuries, among other illnesses that would have interfered with treatment or evaluations, were not allowed to participate.
- Individuals who had significant hearing or vision impairments that would have hampered treatment or evaluations were not included.
- Individuals undergoing anti-spatial therapy or other clinical trials, those with bilateral brain lesions, and those with ischemic involvement of the cerebellum or basal ganglia were not allowed to participate.
- Participants having metal implants e. g cardiac pacemaker and skin lesion at the site of stimulation electrodes were excluded.
Key Trial Info
Start Date :
April 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06927206
Start Date
April 10 2025
End Date
September 30 2025
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinnah Hospital
Lahore, Punjab Province, Pakistan, 54660